<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>38</CFRTITLE>
    <CFRTITLETEXT>Pensions, Bonuses, and Veterans' Relief</CFRTITLETEXT>
    <VOL>1</VOL>
    <DATE>2006-07-01</DATE>
    <ORIGINALDATE>2006-07-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Schedule of ratings-eye.</TITLE>
    <GRANULENUM>4.84a</GRANULENUM>
    <HEADING>Section 4.84a</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 38" SEQ="4">Pensions, Bonuses, and Veterans' Relief</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="3">DEPARTMENT OF VETERANS AFFAIRS</PARENT>
      <PARENT HEADING="PART 4" SEQ="2">SCHEDULE FOR RATING DISABILITIES</PARENT>
      <PARENT HEADING="Subpart B" SEQ="1">Disability Ratings</PARENT>
      <PARENT HEADING="" SEQ="0">The Organs of Special Sense</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 4.84a</SECTNO>
    <SUBJECT>Schedule of ratings—eye.</SUBJECT>
    <GPOTABLE CDEF="s50,5" COLS="2" OPTS="L2">
      <TTITLE>Diseases of the Eye</TTITLE>
      <BOXHD>
        <CHED H="1"/>
        <CHED H="1">Rating</CHED>
      </BOXHD>
      <ROW>
        <ENT I="22">6000Uveitis</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6001Keratitis</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6002Scleritis</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6003Iritis</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6004Cyclitis</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6005Choroiditis</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6006Retinitis</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6007Hemorrhage, intra-ocular, recent</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6008Retina, detachment of</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6009Eye, injury of, unhealed:</ENT>
      </ROW>
      <ROW>
        <PRTPAGE P="408"/>
        <ENT I="02">The above disabilities, in chronic form, are to be rated from 10 percent to 100 percent for impairment of visual acuity or field loss, pain, rest-requirements, or episodic incapacity, combining an additional rating of 10 percent during continuance of active pathology. Minimum rating during active pathology</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6010Eye, tuberculosis of, active or inactive:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Active</ENT>
        <ENT>100</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Inactive: See §§ 4.88b and 4.89.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6011Retina, localized scars, atrophy, or irregularities of, centrally located, with irregular, duplicated enlarged or diminished image:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral or bilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6012Glaucoma, congestive or inflammatory:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Frequent attacks of considerable duration; during continuance of actual total disability</ENT>
        <ENT>100</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or, rate as iritis, diagnostic Code 6003.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6013Glaucoma, simple, primary, noncongestive:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate on impairment of visual acuity or field loss.</ENT>
      </ROW>
      <ROW>
        <ENT I="03">Minimum rating</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6014New growths, malignant (eyeball only):</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Pending completion of operation or other indicated treatment</ENT>
        <ENT>100</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Healed; rate on residuals.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6015New growths, benign (eyeball and adnexa, other than superficial)</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Rate on impaired vision, minimum</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Healed; rate on residuals.</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6016Nystagmus, central</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6017Conjunctivitis, trachomatous, chronic:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Active; rate for impairment of visual acuity; minimum rating while there is active pathology</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Healed; rate on residuals, if no residuals</ENT>
        <ENT>0</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6018Conjunctivitis, other, chronic:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Active, with objective symptoms</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Healed; rate on residuals, if no residuals</ENT>
        <ENT>0</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6019Ptosis, unilateral or bilateral:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Pupil wholly obscured.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate equivalent to 5/200 (1.5/60).</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Pupile one-half or more obscured.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate equivalent to 20/100 (6/30).</ENT>
      </ROW>
      <ROW>
        <ENT I="12">With less interference with vision.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate as disfigurement.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6020Ectropion:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6021Entropion:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6022Lagophthalmos:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6023Eyebrows, loss of, complete, unilateral or bilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6024Eyelashes, loss of, complete, unilateral or bilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6025Epiphora (lacrymal duct, interference with, from any cause):</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6026Neuritis, optic:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate underlying disease, and combine impairment of visual acuity or field loss.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6027Cataract, traumatic:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Preoperative.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate on impairment of vision.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Postoperative.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate on impairment of vision and aphakia.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6028Cataract, senile, and others:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Preoperative.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate on impairment of vision.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Postoperative.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate on impairment of vision and aphakia.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6029Aphakia:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral or unilateral</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="12">
          <E T="04">Note:</E> The 30 percent rating prescribed for aphakia is a minimum rating to be applied to the unilateral or bilateral condition and is not to be combined with any other rating for impaired vision. When only one eye is aphakic, the eye having poorer corrected visual acuity will be rated on the basis of its acuity without correction. When both eyes are aphakic, both will be rated on corrected vision. The corrected vision of one or both aphakic eyes will be taken one step worse than the ascertained value, however, not better than 20/70 (6/21). Combined ratings for disabilities of the same eye should not exceed the amount for total loss of vision of that eye unless there is an enucleation or a serious cosmetic defect added to the total loss of vision.</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6030Accommodation, paralysis of</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6031Dacryocystitis</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate as epiphora.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6032Eyelids, loss of portion of:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate as disfigurement. (See diseases of the skin.)</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6033Lens, crystalline, dislocation of:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate as aphakia.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6034Pterygium:</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Rate for loss of vision, if any.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6035Keratoconus: To be evaluated on impairment of corrected visual acuity using contact lenses.</ENT>
      </ROW>
      <ROW>
        <ENT I="12">
          <E T="04">Note:</E> When contact lenses are medically required for keratoconus, either unilateral or bilateral, the minimum rating will be 30 percent.</ENT>
      </ROW>
    </GPOTABLE>
    <PRTPAGE P="409"/>
    <GPOTABLE CDEF="s46,r50,r50,r50p,r50,r50,r50,r50,r50" COLS="9" OPTS="L2">
      <TTITLE>Table IV—Table for Rating Bilateral Blindness or Blindness Combined With Hearing Loss With Dictator's Code and 38 CFR Citations</TTITLE>
      <BOXHD>
        <CHED H="1">Vision one eye</CHED>
        <CHED H="1">Vision other eye</CHED>
        <CHED H="2">5/200 (1.5/60) or less</CHED>
        <CHED H="2">Light perception only</CHED>
        <CHED H="2">No light perception or anatomical loss</CHED>
        <CHED H="1">Plus service-connected Hearing loss</CHED>
        <CHED H="2">Total deafness one ear</CHED>
        <CHED H="2">10% or 20% at least one ear SC</CHED>
        <CHED H="2">30% at least one ear SC</CHED>
        <CHED H="2">40% at least one ear SC</CHED>
        <CHED H="2">60% or more at least one ear SC</CHED>
      </BOXHD>
      <ROW>
        <ENT I="01">5/200 (1.5/60) or less</ENT>
        <ENT>L <SU>1</SU> Code LB-1 38 CFR 3.350(b)(2)</ENT>
        <ENT>L+<FR>1/2</FR>
          <SU>1</SU> Code LB-2 38 CFR 3.350(f)(2)(i)</ENT>
        <ENT>M Code MB-2 a or b 38 CFR 3.350(f)(2)(ii)</ENT>
        <ENT>Add <FR>1/2</FR> step Code PB-1 38 CFR 3.350(f)(2)(iv)</ENT>
        <ENT>No additional SMC</ENT>
        <ENT>Add a full step Code PB-3 38 CFR 3.350(f)(2)(vi)</ENT>
        <ENT>Add a full step Code PB-3 38 CFR 3.350(f)(2)(vi)</ENT>
        <ENT>O Code OB-1 38 CFR 3.350(e)(1)(iii)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">Light perception only</ENT>
        <ENT/>
        <ENT>M Code MB-1 a 38 CFR 3.350(c)(1)((iv)</ENT>
        <ENT>M+<FR>1/2</FR> Code MB-3 a or b 38 CFR 3.350(f)(iii)</ENT>
        <ENT>O Code OB-2 38 CFR 3.350(e)(1)(iv)</ENT>
        <ENT>Add <FR>1/2</FR> step Code PB-2 38 CFR 3.350(f)(2)(v)</ENT>
        <ENT>Add a full step Code PB-3 38 CFR 3.350(f)(2)(iv)</ENT>
        <ENT>O Code OB-2 38 CFR 3.350(e)(1)(iv)</ENT>
        <ENT>O Code OB-1 38 CFR 3.350(e)(1)(iii)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">No light perception or anatomical loss</ENT>
        <ENT/>
        <ENT/>
        <ENT>N Code NB-1 a-b or c 38 CFR 3.350(d)(4)</ENT>
        <ENT>O Code OB-2 38 CFR 3.350(e)(1)(iv)</ENT>
        <ENT>Add <FR>1/2</FR> step Code PB-2 38 CFR 3.350(f)(2)(v)</ENT>
        <ENT>Add full step Code PB-3 38 CFR 3.350(f)(2)(vi)</ENT>
        <ENT>O Code OB-2 38 CFR 3.350(e)(1)(iv)</ENT>
        <ENT>O Code OB-1 38 CFR 3.350(e)(1)(iii)</ENT>
      </ROW>
      <TNOTE>
        <SU>1</SU> With need for aid and attendance qualifies for Subpar. m. code MB-1, b; 38 CFR 3.350(c)(1)(v).</TNOTE>
      
      <TNOTE>
        <E T="04">Note.</E> (1) Any of the additional SMC payable under Dictator's Codes PB-1, PB-2, or PB-3 is not to exceed the rate payable under Subpar. O. (2) If in addition to any of the above the veteran has the service-connected loss or loss of use of an extremity, additional SMC is payable, not to exceed the rate payable under Subpar. O. See Dictator's Codes PB-4, PB-5, PB-6, and 38 CFR 3.350(f)(2)(vii) (A), (B), (C).</TNOTE>
    </GPOTABLE>
    <PRTPAGE P="410"/>
    <PARAUTH>(Authority: 38 U.S.C. 1115)</PARAUTH>
    <GPOTABLE CDEF="s50,5" COLS="2" OPTS="L2">
      <TTITLE>Impairment of Central Visual Acuity</TTITLE>
      <BOXHD>
        <CHED H="1"/>
        <CHED H="1">Rating</CHED>
      </BOXHD>
      <ROW>
        <ENT I="01">6061Anatomical loss both eyes</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6062Blindness in both eyes having only light perception</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Anatomical loss of 1 eye:</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6063In the other eye 5/200 (1.5/60)</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6064In the other eye 10/200 (3/60)</ENT>
        <ENT>
          <SU>6</SU> 90</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6064In the other eye 15/200 (4.5/60)</ENT>
        <ENT>
          <SU>6</SU> 80</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6064In the other eye 20/200 (6/60)</ENT>
        <ENT>
          <SU>6</SU> 70</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6065In the other eye 20/100 (6/30)</ENT>
        <ENT>
          <SU>6</SU> 60</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6065In the other eye 20/70 (6/21)</ENT>
        <ENT>
          <SU>6</SU> 60</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6065In the other eye 20/50 (6/15)</ENT>
        <ENT>
          <SU>6</SU> 50</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6066In the other eye 20/40 (6/12)</ENT>
        <ENT>
          <SU>6</SU> 40</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Blindness in 1 eye, having only light perception:</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6067In the other eye 5/200 (1.5/60)</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6068In the other eye 10/200 (3/60)</ENT>
        <ENT>
          <SU>5</SU> 90</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6068In the other eye 15/200 (4.5/60)</ENT>
        <ENT>
          <SU>5</SU> 80</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6068In the other eye 20/200 (6/60)</ENT>
        <ENT>
          <SU>5</SU> 70</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6069In the other eye 20/100 (6/30)</ENT>
        <ENT>
          <SU>5</SU> 60</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6069In the other eye 20/70 (6/21)</ENT>
        <ENT>
          <SU>5</SU> 50</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6069In the other eye 20/50 (6/15)</ENT>
        <ENT>
          <SU>5</SU> 40</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6070In the other eye 20/40 (6/12)</ENT>
        <ENT>
          <SU>5</SU> 30</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 5/200 (1.5/60):</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6071In the other eye 5/200 (1.5/60)</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6072In the other eye 10/200 (3/60)</ENT>
        <ENT>90</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6072In the other eye 15/200 (4.5/60)</ENT>
        <ENT>80</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6072In the other eye 20/200 (6/60)</ENT>
        <ENT>70</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6073In the other eye 20/100 (6/30)</ENT>
        <ENT>60</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6073In the other eye 20/70 (6/21)</ENT>
        <ENT>50</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6073In the other eye 20/50 (6/15)</ENT>
        <ENT>40</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6074In the other eye 20/40 (6/12)</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 10/200 (3/60):</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6075In the other eye 10/200 (3/60)</ENT>
        <ENT>90</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6075In the other eye 15/200 (4.5/60)</ENT>
        <ENT>80</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6075In the other eye 20/200 (6/60)</ENT>
        <ENT>70</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/100 (6/30)</ENT>
        <ENT>60</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/70 (6/21)</ENT>
        <ENT>50</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/50 (6/15)</ENT>
        <ENT>40</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6077In the other eye 20/40 (6/12)</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 15/200 (4.5/60):</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6075In the other eye 15/200 (4.5/60)</ENT>
        <ENT>80</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6075In the other eye 20/200 (6/60)</ENT>
        <ENT>70</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/100 (6/30)</ENT>
        <ENT>60</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/70 (6/21)</ENT>
        <ENT>40</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/50 (6/15)</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6077In the other eye 20/40 (6/12)</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 20/200 (6/60):</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6075In the other eye 20/200 (6/60)</ENT>
        <ENT>70</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/100 (6/30)</ENT>
        <ENT>60</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/70 (6/21)</ENT>
        <ENT>40</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6076In the other eye 20/50 (6/15)</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6077In the other eye 20/40 (6/12)</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 20/100 (6/30):</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6078In the other eye 20/100 (6/30)</ENT>
        <ENT>50</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6078In the other eye 20/70 (6/21)</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6078In the other eye 20/50 (6/15)</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6079In the other eye 20/40 (6/12)</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 20/70 (6/21):</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6078In the other eye 20/70 (6/21)</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6078In the other eye 20/50 (6/15)</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6079In the other eye 20/40 (6/12)</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 20/50 (6/15):</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6078In the other eye 20/50 (6/15)</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6079In the other eye 20/40 (6/12)</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Vision in 1 eye 20/40 (6/12):</ENT>
      </ROW>
      <ROW>
        <ENT I="12">In the other eye 20/40 (6/12)</ENT>
        <ENT>0</ENT>
      </ROW>
      <TNOTE>
        <SU>5</SU> Also entitled to special monthly compensation.</TNOTE>
      <TNOTE>
        <SU>6</SU> Add 10% if artificial eye cannot be worn; also entitled to special monthly compensation.</TNOTE>
    </GPOTABLE>
    <GPOTABLE CDEF="xl20,8,8,8,8,8,8,8,8,12" COLS="10" OPTS="L2">
      <TTITLE>Table V—Ratings for Central Visual Acuity Impairment</TTITLE>
      <TDESC>[With Diagnostic Code]</TDESC>
      <BOXHD>
        <CHED H="1">Vision in one eye</CHED>
        <CHED H="1">Vision in other eye</CHED>
        <CHED H="2">20/40 (6/12)</CHED>
        <CHED H="2">20/50 (6/15)</CHED>
        <CHED H="2">20/70 (6/21)</CHED>
        <CHED H="2">20/100 (6/30)</CHED>
        <CHED H="2">20/200 (6/60)</CHED>
        <CHED H="2">15/200 (4.5/60)</CHED>
        <CHED H="2">10/200 (3/60)</CHED>
        <CHED H="2">5/200 (1.5/60)</CHED>
        <CHED H="2">Light perception only/anatomical loss</CHED>
      </BOXHD>
      <ROW>
        <ENT I="01">20/40</ENT>
        <ENT>0</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(6/12)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">20/50</ENT>
        <ENT>10</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(6/15)</ENT>
        <ENT>(6079)</ENT>
        <ENT>(6078)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">20/70</ENT>
        <ENT>10</ENT>
        <ENT>20</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(6/21)</ENT>
        <ENT>(6079)</ENT>
        <ENT>(6078)</ENT>
        <ENT>(6078)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">20/100</ENT>
        <ENT>10</ENT>
        <ENT>20</ENT>
        <ENT>30</ENT>
        <ENT>50</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(6/30)</ENT>
        <ENT>(6079)</ENT>
        <ENT>(6078)</ENT>
        <ENT>(6078)</ENT>
        <ENT>(6078)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">20/200</ENT>
        <ENT>20</ENT>
        <ENT>30</ENT>
        <ENT>40</ENT>
        <ENT>60</ENT>
        <ENT>70</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(6/60)</ENT>
        <ENT>(6077)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6075)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">15/200</ENT>
        <ENT>20</ENT>
        <ENT>30</ENT>
        <ENT>40</ENT>
        <ENT>60</ENT>
        <ENT>70</ENT>
        <ENT>80</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(4.5/60)</ENT>
        <ENT>(6077)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6075)</ENT>
        <ENT>(6075)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">10/200</ENT>
        <ENT>30</ENT>
        <ENT>40</ENT>
        <ENT>50</ENT>
        <ENT>60</ENT>
        <ENT>70</ENT>
        <ENT>80</ENT>
        <ENT>90</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(3/60)</ENT>
        <ENT>(6077)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6076)</ENT>
        <ENT>(6075)</ENT>
        <ENT>(6075)</ENT>
        <ENT>(6075)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">5/200</ENT>
        <ENT>30</ENT>
        <ENT>40</ENT>
        <ENT>50</ENT>
        <ENT>60</ENT>
        <ENT>70</ENT>
        <ENT>80</ENT>
        <ENT>90</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="22">(1.5/60)</ENT>
        <ENT>(6074)</ENT>
        <ENT>(6073)</ENT>
        <ENT>(6073)</ENT>
        <ENT>(6073)</ENT>
        <ENT>(6072)</ENT>
        <ENT>(6072)</ENT>
        <ENT>(6072)</ENT>
        <ENT>(6071)</ENT>
      </ROW>
      <ROW>
        <PRTPAGE P="411"/>
        <ENT I="01">Light perception only</ENT>
        <ENT>
          <SU>5</SU> 30</ENT>
        <ENT>
          <SU>5</SU> 40</ENT>
        <ENT>
          <SU>5</SU> 50</ENT>
        <ENT>
          <SU>5</SU> 60</ENT>
        <ENT>
          <SU>5</SU> 70</ENT>
        <ENT>
          <SU>5</SU> 80</ENT>
        <ENT>
          <SU>5</SU> 90</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW RUL="s">
        <ENT I="11"/>
        <ENT>(6070)</ENT>
        <ENT>(6069)</ENT>
        <ENT>(6069)</ENT>
        <ENT>(6069)</ENT>
        <ENT>(6068)</ENT>
        <ENT>(6068)</ENT>
        <ENT>(6068)</ENT>
        <ENT>(6067)</ENT>
        <ENT>(6062)</ENT>
      </ROW>
      <ROW>
        <ENT I="01">Anatomical loss of one eye</ENT>
        <ENT>
          <SU>6</SU> 40</ENT>
        <ENT>
          <SU>6</SU> 50</ENT>
        <ENT>
          <SU>6</SU> 60</ENT>
        <ENT>
          <SU>6</SU> 60</ENT>
        <ENT>
          <SU>6</SU> 70</ENT>
        <ENT>
          <SU>6</SU> 80</ENT>
        <ENT>
          <SU>6</SU> 90</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
        <ENT>
          <SU>5</SU> 100</ENT>
      </ROW>
      <ROW>
        <ENT I="11"/>
        <ENT>(6066)</ENT>
        <ENT>(6065)</ENT>
        <ENT>(6065)</ENT>
        <ENT>(6065)</ENT>
        <ENT>(6064)</ENT>
        <ENT>(6064)</ENT>
        <ENT>(6064)</ENT>
        <ENT>(6063)</ENT>
        <ENT>(6061)</ENT>
      </ROW>
      <TNOTE>
        <SU>5</SU> Also entitled to special monthly compensation.</TNOTE>
      <TNOTE>
        <SU>6</SU>Add 10 percent if artificial eye cannot be worn; also entitled to special monthly compensation.</TNOTE>
    </GPOTABLE>
    <GPOTABLE CDEF="s50,5" COLS="2" OPTS="L2">
      <TTITLE>Ratings for Impairment of Field Vision</TTITLE>
      <BOXHD>
        <CHED H="1"/>
        <CHED H="1">Rating</CHED>
      </BOXHD>
      <ROW>
        <ENT I="22">6080Field vision, impairment of:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Homonymous hemianopsia</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="22">Field, visual, loss of temporal half:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or rate as 20/70 (6/21).</ENT>
      </ROW>
      <ROW>
        <ENT I="22">Field, visual, loss of nasal half:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or rate as 20/50 (6/15).</ENT>
      </ROW>
      <ROW>
        <ENT I="22">Field, visual, concentric contraction of:</ENT>
      </ROW>
      <ROW>
        <ENT I="11">To 5°:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>100</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or rate as 5/200 (1.5/60).</ENT>
      </ROW>
      <ROW>
        <ENT I="11">To 15° but not to 5°:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>70</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or rate as 20/200 (6/60).</ENT>
      </ROW>
      <ROW>
        <ENT I="11">To 30° but not to 15°:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>50</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or rate as 20/100 (6/30).</ENT>
      </ROW>
      <ROW>
        <ENT I="11">To 45° but not to 30°:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>30</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or rate as 20/70 (6/21):</ENT>
      </ROW>
      <ROW>
        <ENT I="11">To 60° but not to 45°:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Bilateral</ENT>
        <ENT>20</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Unilateral</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">Or rate as 20/50 (6/15).</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Note (1): Correct diagnosis reflecting disease or injury should be cited.</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Note (2): Demonstrable pathology commensurate with the functional loss will be required. The concentric contraction ratings require contraction within the stated degrees, temporally; the nasal contraction may be less. The alternative ratings are to be employed when there is ratable defect of visual acuity, or a different impairment of the visual field in the other eye. Concentric contraction resulting from demonstrable pathology to 5 degrees or less will be considered on a parity with reduction of central visual acuity to 5/200 (1.5/60) or less for all purposes including entitlement under § 3.350(b)(2) of this chapter; not however, for the purpose of § 3.350(a) of this chapter. Entitlement on account of blindness requiring regular aid and attendance, § 3.350(c) of this chapter, will continue to be determined on the facts in the individual case.</ENT>
      </ROW>
      <ROW>
        <ENT I="22">6081Scotoma, pathological, unilateral:</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Large or centrally located, minimum</ENT>
        <ENT>10</ENT>
      </ROW>
      <ROW>
        <ENT I="12">
          <E T="04">Note:</E> Rate on loss of central visual acuity or impairment of field vision. Do not combine with any other rating for visual impairment.</ENT>
      </ROW>
    </GPOTABLE>
    <GPOTABLE CDEF="s25,6" COLS="2" OPTS="L2">
      <TTITLE>Ratings for Impairment of Muscle Function</TTITLE>
      <TDESC>[6090Diplopia (double vision)]</TDESC>
      <BOXHD>
        <CHED H="1">Degree of diplopia</CHED>
        <CHED H="1">Equivalent visual acuity</CHED>
      </BOXHD>
      <ROW>
        <ENT I="01">(a) Central 20°</ENT>
        <ENT>5/200</ENT>
      </ROW>
      <ROW>
        <ENT I="11">(b) 21° to 30°:</ENT>
      </ROW>
      <ROW>
        <ENT I="01">(1) Down</ENT>
        <ENT>15/200</ENT>
      </ROW>
      <ROW>
        <ENT I="01">(2) Lateral</ENT>
        <ENT>20/100</ENT>
      </ROW>
      <ROW>
        <ENT I="01">(3) Up</ENT>
        <ENT>20/70</ENT>
      </ROW>
      <ROW>
        <ENT I="11">(c) 31° to 40°:</ENT>
      </ROW>
      <ROW>
        <ENT I="01">(1) Down</ENT>
        <ENT>20/200</ENT>
      </ROW>
      <ROW>
        <ENT I="01">(2) Lateral</ENT>
        <ENT>20/70</ENT>
      </ROW>
      <ROW>
        <ENT I="01">(3) Up</ENT>
        <ENT>20/40
        </ENT>
      </ROW>
      <ROW>
        <ENT I="02">Note: (1) Correct diagnosis reflecting disease or injury should be cited.</ENT>
      </ROW>
      <ROW>
        <PRTPAGE P="412"/>
        <ENT I="02">Note: (2) The above ratings will be applied to only one eye. Ratings will not be applied for both diplopia and decreased visual acuity or field of vision in the same eye. When diplopia is present and there is also ratable impairment of visual acuity or field of vision of both eyes the above diplopia ratings will be applied to the poorer eye while the better eye is rated according to the best corrected visual acuity or visual field.</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Note: (3) When the diplopia field extends beyond more than one quadrant or more than one range of degrees, the evaluation for diplopia will be based on the quadrant and degree range that provide the highest evaluation.</ENT>
      </ROW>
      <ROW>
        <ENT I="02">Note: (4) When diplopia exists in two individual and separate areas of the same eye, the equivalent visual acuity will be taken one step worse, but no worse than 5/200.
        </ENT>
      </ROW>
      <ROW>
        <ENT I="01">6091Symblepharon.</ENT>
      </ROW>
      <ROW>
        <ENT I="01">Rate as limited muscle function, diagnostic code 6090.</ENT>
      </ROW>
      <ROW>
        <ENT I="01">6092Diplopia, due to limited muscle function.</ENT>
      </ROW>
      <ROW>
        <ENT I="01">Rate as diagnostic code 6090.</ENT>
      </ROW>
    </GPOTABLE>
    <CITA>[29 FR 6718, May 22, 1964, as amended at 34 FR 5062, Mar. 11, 1969; 40 FR 42537, Sept. 15, 1975; 41 FR 11297, Mar. 18, 1976; 43 FR 45354, Oct. 2, 1978; 51 FR 6411, Feb. 24, 1986; 53 FR 30264, Aug. 11, 1988; 53 FR 50955, Dec. 19, 1988; 57 FR 24364, June 9, 1992]</CITA>
  </SECTION>
  <SUBJGRP>
    <HD SOURCE="HED">Impairment of Auditory Acuity</HD>
  </SUBJGRP>
</CFRGRANULE>

